Main Authors: | Roberto Ravasio, Silvia Antonelli, Alessia Maiorino, Antonio Costanzo, Serena Losi |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2019-01-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/468 |
Similar Items
-
Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy
by: Roberto Ravasio, et al.
Published: (2019-01-01) -
Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy
by: Roberto Ravasio, et al.
Published: (2021-04-01) -
by: Roberto Ravasio, et al.
Published: (2018-07-01) -
Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy
by: Roberto Ravasio, et al.
Published: (2018-07-01) -
Evolution of EC8 Seismic Design Rules for X Concentric Bracings
by: Alessia Campiche, et al.
Published: (2020-10-01)